<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04900701</url>
  </required_header>
  <id_info>
    <org_study_id>201209-B-01</org_study_id>
    <nct_id>NCT04900701</nct_id>
  </id_info>
  <brief_title>The Impact of Energy Intake and Short-term Disuse on Muscle Protein Synthesis Rates and Skeletal Muscle Mass in Middle-aged Adults.</brief_title>
  <acronym>PIE</acronym>
  <official_title>The Impact of Energy Intake and Short-term Disuse on Muscle Protein Synthesis Rates and Skeletal Muscle Mass in Middle-aged Adults.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Exeter</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Exeter</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In healthy middle-aged men and women, what is the effect of dietary energy restriction and&#xD;
      energy surplus on daily muscle protein synthesis rates and muscle morphology, compared to&#xD;
      energy balance, during free-living and immobilisation?&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background As we age we lose muscle tissue, which is associated with a number of negative&#xD;
      health outcomes. This loss of muscle tissue is partially caused by blunted muscle protein&#xD;
      synthesis rates (MPS) in response to food ingestion, which is exacerbated by muscle disuse.&#xD;
      Concomitantly, consuming an energy balanced diet appears to become more challenging with&#xD;
      advancing age, due to a reduction in appetite. Of concern is that the impact of energy intake&#xD;
      on muscle protein metabolism during ageing is poorly characterised.&#xD;
&#xD;
      Objective To determine daily MPS and muscle morphology in response to differing energy&#xD;
      intakes, in free-living conditions and during immobilisation.&#xD;
&#xD;
      Methods Healthy middle-aged volunteers will consume a hypocaloric, energy-balanced, or&#xD;
      hypercaloric diet (providing 1.4 g.kg.day protein) over a three-day free-living period, and a&#xD;
      three day period of single leg immobilisation. Deuterium oxide and MRI scans will be used to&#xD;
      measure daily MPS and muscle size, respectively.&#xD;
&#xD;
      Value The study will determine the effect of energy intake per se on daily muscle protein&#xD;
      synthesis rates and muscle size, in free-living and immobilised conditions. This will inform&#xD;
      how energy provision modulates tissue loss with ageing, and how this interacts with the&#xD;
      catabolic stress of muscle disuse.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">May 2021</start_date>
  <completion_date type="Anticipated">January 2024</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Muscle protein synthesis (MPS)</measure>
    <time_frame>6 days (3 days free-living, 3 days immobilised)</time_frame>
    <description>Daily muscle protein synthesis rates, expressed as fractional synthetic rate (FSR) (%/day)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Muscle morphology.</measure>
    <time_frame>3 day immobilisation phase.</time_frame>
    <description>Changes in muscle size, measured via MRI scanning, during immobilisation.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">36</enrollment>
  <condition>Muscle Atrophy</condition>
  <condition>Aging</condition>
  <condition>Energy Malnutrition Protein</condition>
  <arm_group>
    <arm_group_label>Hypocaloric</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants placed in energy restriction.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Energy Balance</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants placed in energy balance.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hypercaloric</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants placed in energy surplus.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Energy status</intervention_name>
    <description>Varying conditions of energy intake, thereby manipulating whether participants are in a state of energy restriction, balance, or surplus.</description>
    <arm_group_label>Energy Balance</arm_group_label>
    <arm_group_label>Hypercaloric</arm_group_label>
    <arm_group_label>Hypocaloric</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Age 35-65 Healthy Non-smoker Recreationally active&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Any diagnosed metabolic impairment (e.g. type 1 or 2 Diabetes) Any diagnosed cardiovascular&#xD;
        disease or hypertension Elevated blood pressure at the time of screening. (An average&#xD;
        systolic blood pressure reading of ≥150mmHg over two or more measurements and an average&#xD;
        diastolic blood pressure of ≥90mmHg over two or more measurements.) Chronic use of diabetic&#xD;
        medication. A personal or family history of epilepsy, seizures or schizophrenia. Allergic&#xD;
        to mycoprotein / Quorn, penicillin, or cow's milk. Any musculoskeletal injury that may&#xD;
        impair their use of crutches. Any diagnosed severe digestive illness. Any diagnosed severe&#xD;
        autoimmune disease. Any diagnosed cancer. Any metal fragments in your eyes, a pacemaker, or&#xD;
        metal implants in your body that preclude MRI scanning.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Alistair Monteyne, PhD</last_name>
    <phone>+44 (0)1392 72 4774</phone>
    <email>a.monteyne2@exeter.ac.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Benjamin Wall, PhD</last_name>
    <phone>+44 (0)1392 72 4774</phone>
    <email>b.t.wall@exeter.ac.uk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Sport &amp; Health Sciences University of Exeter</name>
      <address>
        <city>Exeter</city>
        <state>Devon</state>
        <zip>EX1 2LU</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Benjamin T Wall, PhD</last_name>
      <phone>+441392 724774</phone>
      <phone_ext>4774</phone_ext>
      <email>b.t.wall@exeter.ac.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Exeter, Sports &amp; Health Sciences, College of Life &amp; Environmental Sciences</name>
      <address>
        <city>Exeter</city>
        <state>Devon</state>
        <zip>EX1 2LU</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Benjamin T Wall</last_name>
      <phone>+441392724774</phone>
      <email>B.T.Wall@exeter.ac.uk</email>
    </contact>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 20, 2021</study_first_submitted>
  <study_first_submitted_qc>May 20, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 25, 2021</study_first_posted>
  <last_update_submitted>May 20, 2021</last_update_submitted>
  <last_update_submitted_qc>May 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Muscle protein synthesis</keyword>
  <keyword>Ageing</keyword>
  <keyword>Dietary protein</keyword>
  <keyword>Disuse</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Muscular Atrophy</mesh_term>
    <mesh_term>Malnutrition</mesh_term>
    <mesh_term>Protein-Energy Malnutrition</mesh_term>
    <mesh_term>Atrophy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

